Status:

COMPLETED

Efficacy of Olibra: A 12 Week Controlled Trial

Lead Sponsor:

Pennington Biomedical Research Center

Collaborating Sponsors:

GNC

Conditions:

Overweight

Obesity

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

Today's obesogenic environment, favors behavioral choices that lead to an excess of energy intake over expenditure, and consequently weight gain. Intervention strategies that harness the body's own ap...

Detailed Description

71 healthy subjects were enrolled (60 females, 11 males; Age: 18 - 60 years, BMI 25 - 40 kg/m2) in a two-phased, randomized, placebo-controlled, double-blind, parallel trial. During a 12-week period, ...

Eligibility Criteria

Inclusion

  • Healthy subjects of both sexes 18 - 60 years of age
  • body mass index (BMI) between 25 and 40 kg/m2, inclusive

Exclusion

  • (1) participation in another clinical trial or receipt of an investigational product 30 days prior to enrollment
  • (2) a dietary restraint score of \> 13
  • (3) weight loss of 4.5 kg or more in the preceding three months
  • (4) use of tobacco products, nicotine gum or nicotine patch
  • (5) a medical condition or taking regular medication except oral contraceptives and hormone replacement therapy
  • (6) use of a nutritional product or dietary supplement or program which might interfere with the conduct of the study or place the subject at risk
  • (7) history of alcohol or other drug abuse in the preceding one year
  • (8) pregnancy, lactation, post-partum less than six months, planning a pregnancy during the study or not using an acceptable method of contraception
  • (9) fasting blood sugar ≥ 126 mg/dl
  • (10) known allergy or sensitivity to any ingredient in the supplement
  • (11) clinically significant deviations in normal laboratory values
  • (12) irregular meal-times, and
  • (13) unwilling to eat yogurt at test meals.

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2006

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT01416051

Start Date

January 1 2005

End Date

November 1 2006

Last Update

December 18 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Pennington Biomedical Research Center

Baton Rouge, Louisiana, United States, 70808